Takeda Joins 5th ADC Summit to Discuss ADCETRIS Development

London, UK, February 5, 2016 (Newswire.com) - ​SMi is pleased to announce that Ashish Gautam, Global Medical Lead - ADCETRIS from Takeda, has joined the expert speaker line-up at the 5th annual ADC Summit taking place on 23 - 24 May in London, UK. Registration to the conference is now live with a special discount of £400 for bookings (before 29 February) at http://www.adcsummit.com/newswire

Ashish will be opening Day Two of the conference with a keynote address entitled "ADCETRIS developed to treat Hodgkin Lymphoma" and will explore:

• Development of ADCETRIS - the Takeda and Seattle Genetics alliance
• Exploring the mechanism pathway of ADCETRIS
• Data published to date from ADCETRIS registration studies
• Ongoing ADCETRIS clinical development

Join industry leaders as they share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success. Check out the full agenda at http://www.adcsummit.com/newswire.

Other presentations include:

• Challenges and lessons learnt in ADC CMC development and outsourcing      
  Jens Lorhmann, Senior Global Program Manager, Novartis​
  ​
• Advancement in antibody grug conjugates: a step closer to magic bullets in war against cancer
  Rakesh Dixit, Vice President, R&D, Medimmune
  ​
• Impact of drug loading on ADC target binding and cytotoxicity
  Debbie Meyer, Senior Principal Scientist, Pfizer
   
• Predicting tissue distribution and clearance of antibody formats to improve selectivity of targeted therapies
  Ben-Fillippo Krippendeorff, Principal Scientist, Roche
   
• The design, synthesis and scale-up of an ADC tubulysin      
  Jeremy Parker, Principal Scientist, Pharmaceutical Development, AstraZeneca and many more.

The full speaker lineup can be found on http://www.adcsummit.com/newswire.

In addition to the conference, the event will feature two exclusive half-day post-conference workshops held on the 25 May 2016:

1. ADC payloads: Availability and mechanisms of action
   Hosted by Femtogenix and King’s Cross London
2. Developments in high potency API manufacturing
   Hosted by SKAN AG

For more information or to register visit the event website at http://www.adcsummit.com/newswire
 To take advantage of the EARLY BIRD OFFER register before 29 February to save £400 off the conference price.

For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk
For delegate bookings contact Fateja Begum on +44 (0) 20 7827 6184 or email fbegum@smi-online.co.uk
For media enquiries contact Honey de Gracia on +44 (0) 20 7827 6102 or email hdegracia@smi-online.co.uk

5th ADC Summit
23-24 May 2016
London, UK
Contact e-mail: hdegracia@smi-online.co.uk
Contact number: +44 (0) 207 827 6102
Event Website: www.adcsummit.com/newswire